SEC Form 4 · accession 0001209191-19-015702
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sushma Shivaswamy
Officer — Chief Scientific Officer
Period of report
Jan 4, 2019
Accepted (ET)
Mar 4, 2019 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $5.26 | Jan 4, 2019 | A | 15,000 | A | Jan 4, 2020 | Jan 4, 2029 | Common Stock | 15,000 | 15,000 | D |
Remarks
On January 04, 2019 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.